Page 301 - Read Online

Lei et al. HLH presenting as ACS

9. Hejblum G, Lambotte O, Galicier L, Coppo P, Marzac C, Aumont copy number in patients with EBV-associated hemophagocytic
C, Fardet L. A web-based delphi study for eliciting helpful criteria in lymphohistiocytosis. Leuk Lymphoma 2002;43:173-9.
the positive diagnosis of hemophagocytic syndrome in adult patients. 21. Smith MC, Cohen DN, Greig B, Yenamandra A, Vnencak-Jones C,
PLoS One 2014;9:e94024. Thompson MA, Kim AS. The ambiguous boundary between EBV-
10. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan related hemophagocytic lymphohistiocytosis and systemic EBV-
D, Coppo P, Hejblum G. Development and validation of the HScore, driven T cell lymphoproliferative disorder. Int J Clin Exp Pathol
a score for the diagnosis of reactive hemophagocytic syndrome. 2014;7:5738-49.
Arthritis Rheumatol 2014;66:2613-20. 22. Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, Tian X.
11. Barba T, Maucort-Boulch D, Iwaz J, Bohé J, Ninet J, Hot A, Lega Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult
JC, Guérin C, Argaud L, Broussolle C, Jamilloux Y, Richard JC, patients. Medicine (Baltimore) 2014;93:100-5.
Sève P. Hemophagocytic lymphohistiocytosis in intensive care unit: 23. Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-
a 71-case strobe-compliant retrospective study. Medicine (Baltimore) 2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-
2015;94:e2318. associated hemophagocytic syndrome. Ann Hematol 2014;93:821-6.
12. Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem 24. Tabata C, Tabata R. Possible prediction of underlying lymphoma by
M. The role of the initial bone marrow aspirate in the diagnosis high sIL-2R/ferritin ratio in hemophagocytic syndrome. Ann Hematol
of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2012;91:63-71.
2008;51:402-4. 25. Jiang T, Ding X, Lu W. The prognostic significance of beta2
13. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, microglobulin in patients with hemophagocytic lymphohistiocytosis.
Hahn EG. Multifactorial risk analysis of bone marrow histiocytic Dis Markers 2016;2016:1523959.
hyperplasia with hemophagocytosis in critically ill medical 26. Imashuku S, Hibi S, Tabata Y, Itoh E, Hashida T, Tsunamoto K, Ishimoto
patients--a postmortem clinicopathologic analysis. Crit Care Med K, Kawano F. Outcome of clonal hemophagocytic lymphohistiocytosis:
2004;32:1316-21. analysis of 32 cases. Leuk Lymphoma 2000;37:577-84.
14. Jung SY. Hemophagocytic syndrome diagnosed by liver biopsy in a 27. Ahn JS, Rew SY, Shin MG, Kim HR, Yang DH, Cho D, Kim SH,
female patient with systemic lupus erythematosus. J Clin Rheumatol Bae SY, Lee SR, Kim YK, Kim HJ, Lee JJ. Clinical significance
2013;19:449-51. of clonality and Epstein-Barr virus infection in adult patients with
15. Ju HY, Hong CR, Kim SJ, Lee JW, Kim H, Kang HJ, Park KD, Shin hemophagocytic lymphohistiocytosis. Am J Hematol 2010;85:719-22.
HY, Chae JH, Phi JH, Cheon JE, Park SH, Ahn HS. Hemophagocytic 28. Matsuda K, Nakazawa Y, Yanagisawa R, Honda T, Ishii E, Koike
lymphohistiocytosis diagnosed by brain biopsy. Korean J Pediatr K. Detection of T-cell receptor gene rearrangement in children with
2015;58:358-61. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
16. Ferry JA. Hematolymphoid tumors of the gastrointestinal tract, using the BIOMED-2 multiplex polymerase chain reaction combined
hepatobiliary tract, and pancreas. Odze and Goldblum’s Surgical with GeneScan analysis. Clin Chim Acta 2011;412:1554-8.
Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 3rd ed. 29. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M,
Amsterdam, The Netherlands: Elsevier; 2015. p. 879. Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N.
17. Favara BE. Histopathology of the liver in histiocytosis syndromes. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-
Pediatr Pathol Lab Med 1996;16:413-33. associated hemophagocytic syndrome. J Clin Invest 1993;92:1444-50.
18. Kapelari K, Fruehwirth M, Heitger A, Königsrainer A, Margreiter R, 30. Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH,
Simma B, Offner FA. Loss of intrahepatic bile ducts: an important Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI;
feature of familial hemophagocytic lymphohistiocytosis. Virchows Histiocyte Society. Chemoimmunotherapy for hemophagocytic
Arch 2005;446:619-25. lymphohistiocytosis: long-term results of the HLH-94 treatment
19. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys protocol. Blood 2011;118:4577-84.
P, Wouters C. Macrophage activation syndrome: characteristic 31. Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and
findings on liver biopsy illustrating the key role of activated, IFN- outcomes of adult patients with hemophagocytic lymphohistiocytosis.
gamma-producing lymphocytes and IL-6- and TNF-alpha-producing Am J Hematol 2015;90:220-4.
macrophages. Blood 2005;105:1648-51. 32. Oto M, Yoshitsugu K, Uneda S, Nagamine M, Yoshida M. Prognostic
20. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku factors and outcomes of adult-onset hemophagocytic lymphohistiocytosis:
S. Quantitative analysis of cell-free Epstein-Barr virus genome a retrospective analysis of 34 cases. Hematol Rep 2015;7:5841.

292 Hepatoma Research ¦ Volume 2 ¦ October 21, 2016